Researchers at Queen Mary University of London and Barts Health NHS Trust are looking for clinical trial participants who have recently (within 8 days) been in contact with someone who has tested positive for Covid-19. The STORM CHASER study is looking at whether a combination of two investigational antibodies, developed by AstraZeneca, works in the prevention of COVID-19, following exposure...
An international research collaboration, involving scientists from the UK, US and Spain, has shed new light on the usefulness of digital contact tracing (DCT) to control the spread of Covid-19. The study, published today in Nature Communications, assessed the effectiveness of the Spanish DCT app, Radar COVID, following a 4-week experiment conducted in the Canary Islands, Spain between June-July 2020. For the...
Patients of Asian and black backgrounds suffered disproportionate rates of premature death from Covid-19, according to a study of 1,737 patients by Barts Health NHS Trust and Queen Mary University of London. The study, published in BMJ Open, is one of the most comprehensive studies exploring COVID-19 outcomes in black, Asian and minority ethnic populations so far reported, from one of the largest...
A new study, led by Barts Health NHS Trust and Queen Mary University of London seeks to understand why Black, Asian and minority ethnic communities are disproportionately affected by the Covid-19 virus. People from racial minorities are more likely to become very unwell or die from Covid-19 than those of white ethnicity. Compared to the general population, those of Black African heritage are 3.24 times more likely to die from Covid-19 and Bangladeshi populations are 2.41 times more likely...
A new COVID-19 testing lab at Queen Mary University of London has started processing NHS Test and Trace samples from the UK population, to increase the country’s testing capacity. Scientist processing samples in the Queen Mary COVID-19 testing lab Dr Belinda Nedjai, Senior Lecturer in Molecular Epidemiology and Epigenetics at Queen Mary, who is leading the lab, said: “We’re delighted to...
Congratulations to former Barts Life Sciences CAP-AI data scientist Maryam Abdollahyan and PI Fabrizio Smeraldi, founders of SME Mebomine, https://mebomine.com/ on the pre-print of their paper: Investigating mental and physical disorders associated with COVID-19 in online health forums. https://www.medrxiv.org/content/10.1101/2020.12.14.20248155v1
AIMES, in partnership with University College London (UCL) and Barts Health NHS Trust, developed the OpenCARE platform which uses Artificial Intelligence (AI) to improve cardiovascular care. The project is supported by SBRI Healthcare, an NHS England and NHS Improvement initiative, supported by the Academic Health Science Networks (AHSNs).” Cardiologists rely on images to diagnose and treat heart disease. Some of these...
SNPnexus is an online analytical platform able to streamline complex sequencing data analysis and connect information from different sources allowing for the prioritisation of variant panels associated with disease to facilitate the promise of precision medicine. SNPnexus if freely available for academic and non-profit use only. If you are a commercial user/service provider, or if you are interested in a...
As members of Barts Life Sciences (BLS) – a partnership between Queen Mary and Barts Health NHS Trust – Professors Claude Chelala (CRUK Barts Centre) and Carol Dezateux (IPHS) are – with the generous support of Barts Charity – leading a new initiative to embed computer sciences at a senior level within Queen Mary’s SMD to catalyse innovative precision medicine and population health research. We are recruiting three new professors in computer health sciences...
Dr Musa Abdulkareem is Principal Research Scientist on the Barts Life Sciences CAP-AI programme, where he has been working with Professor Steffen Petersen from Queen Mary University of London to use Artificial Intelligence in analysing cardiac MRI scans. In this Q&A, Dr Abdulkareem reflects on the progress of the project over the last 15 months and talks about his...
Accessibility options
Translate the page